Study title:
Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J
et al. A controlled trial comparing foscarnet with vidarabine for
acyclovir- resistant mucocutaneous herpes-simplex in
the acquired- immunodeficiencysyndrome. New-England-Journalof-
Medicine 325 (8): 551-555.Safrin S, Crumpacker C, Chatis P, Davis R, Hafner R, Rush J
et al. A controlled trial comparing foscarnet with vidarabine for
acyclovir- resistant mucocutaneous herpes-simplex in
the acquired- immunodeficiencysyndrome. New-England-Journalof-
Medicine 325 (8): 551-555.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Virus Diseases [C02]
|
Brands: Please see report, Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: Foscarnet |
ATC code: |
Document link:
Safrin S et al 1991.pdf
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Review Article |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|